Company / Operating Cash Flow per Share
Akebia Therapeutics, Inc. Operating Cash Flow per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.30
FY2025
5-year range
-$1.74 / $0.30
FY2021-FY2025
Trend
+244.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed +245% YoY in FY2025, a notable deviation from the 9-year average annual change of +46%.
Based on SEC 10-K filings.
0.30 in FY2025.
Improved from $-0.13 to $0.30 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 244.7% year-over-year.
- Peak operating cash flow per share was recorded in FY2018.
- Lowest operating cash flow per share in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -2.76 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.30 | +244.7% |
| FY2024 | -$0.21 | -64.5% |
| FY2023 | -$0.13 | +69.3% |
| FY2022 | -$0.41 | +76.2% |
| FY2021 | -$1.74 | -117.0% |
| FY2020 | -$0.80 | -66.8% |
| FY2019 | -$0.48 | -139.5% |
| FY2018 | $1.22 | +318.6% |
| FY2015 | -$0.56 | +89.3% |
| FY2014 | -$5.21 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026